Inactive Instrument

Press Releases Mallinckrodt OTC Markets

Equities

MNKKQ

IE00BBGT3753

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Mallinckrodt Announces Journal Publication of Economic Evidence for TERLIVAZ for Injection in Adults with Hepatorenal Syndrome	Dec. 22	AQ
Mallinckrodt Announces FDA Clearance of the INOmax EVOLVE DS Delivery System and Approval of the INOmax Mini-Cylinder	Dec. 08	AQ
Mallinckrodt to Present Breadth of Data on TERLIVAZ for Injection in Adult Patients with Hepatorenal Syndrome at the American Association for the Study of Liver Diseases 2023 Liver Meeting	Nov. 09	AQ
Mallinckrodt: Q3 Earnings Snapshot	Nov. 07	AQ
Mallinckrodt to Present Data on TERLIVAZ for Injection in Adult Patients with Hepatorenal Syndrome at the American Society of Nephrology Kidney Week 2023 Scientific Meeting	Nov. 02	AQ
Mallinckrodt to Present Data on TERLIVAZ for Injection in Adult Patients with Hepatorenal Syndrome at the American College of Gastroenterology Annual Scientific Meeting	23-10-23	AQ
Mallinckrodt Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate Capsules and Launches Product Used to Treat Attention-Deficit, Hyperactivity Disorder	23-09-01	AQ
MNK Investors Have Opportunity to Lead Mallinckrodt plc Securities Fraud Lawsuit	23-08-30	PR
Mallinckrodt Receives Court Approval for "First Day" Motions to Support Ongoing Operations	23-08-30	PR
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline - MNK	23-08-28	PR
MALLINCKRODT SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Mallinckrodt To Contact Him Directly To Discuss Their Options	23-08-26	PR
MNK Investors Have Opportunity to Lead Mallinckrodt plc Securities Fraud Lawsuit	23-08-22	PR
MNK Investors Have Opportunity to Lead Mallinckrodt plc Securities Fraud Lawsuit	23-08-21	PR
MALLINCKRODT SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Mallinckrodt To Contact Him Directly To Discuss Their Options	23-08-19	PR
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline - MNK	23-08-18	PR
MALLINCKRODT DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Mallinckrodt To Contact Him Directly To Discuss Their Options	23-08-12	PR
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline - MNK	23-08-10	PR
Mallinckrodt plc Reports Second Quarter 2023 Financial Results and Reaffirms Full Year Guidance	23-08-10	AQ
Mallinckrodt: Q2 Earnings Snapshot	23-08-09	AQ
MNK Investors Have Opportunity to Lead Mallinckrodt plc Securities Fraud Lawsuit	23-08-08	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Mallinckrodt OTC Markets

Equities

MNKKQ

IE00BBGT3753

Press Releases

Filters